Real-time enrollment status for this mitral regurgitation clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:35 AM UTC
| NCT Number | NCT04153292 |
| Recruiting Status | Recruiting |
| Condition | Mitral Regurgitation |
| Phase | Clinical Trial |
| Target Enrollment | 900 participants |
| Active Locations | 56 sites in the US |
| Sponsor | Edwards Lifesciences |
| Last Updated on CT.gov | February 25, 2026 (Feb 25, 2026) |
As of July 13, 2026: Clinical trial NCT04153292 is currently recruiting participants. This clinical trial study for mitral regurgitation is actively seeking new participants at 56 locations across the United States. The study is sponsored by Edwards Lifesciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04153292 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 56 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04153292 was last updated Feb 25, 2026 (February 25, 2026). HelloStudys verifies this status automatically.